Why the study?
Hemolytic anemia can occur late after cardiac valve replacement, requiring evaluation of medical therapy versus invasive intervention.
Design
Case report
Authors
Loading...
Medical management may be viable for late hemolytic anemia after valve replacement; case report leaves open need for larger studies.
Highlights that severe hemolytic anemia can occur >20 years post-prosthetic mitral valve replacement and can potentially be managed medically.
Kaur et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: